Skip to content
  • Saturday, 12 September 2026
  • 6:39 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Weekly Gilead and Merck oral HIV regimen maintains suppression in two phase 3 trials
Laboratory Automation & Robotics

Weekly Gilead and Merck oral HIV regimen maintains suppression in two phase 3 trials

Lana Keisha Jul 21, 2026 0

Recent findings presented at the 26th International AIDS Conference have underscored a significant advancement in HIV treatment, with an investigational…

Read More
Pharmaceutical R&D

Kyowa Kirin Secures FDA Approval for Enhanced Crysvita Dosing Regimen for Adults with X-Linked Hypophosphatemia

Teuku Ryan May 16, 2026 0

Kyowa Kirin has announced a significant advancement in the treatment landscape for X-linked hypophosphatemia (XLH) in adult patients, following the…

Read More
Science News: A Century of Empowering Public Understanding of ScienceStanford Medicine Study Identifies Gerozyme Inhibitor Capable of Regenerating Knee Cartilage and Reversing Osteoarthritis DamageInflammatory Remodeling of the Bone Marrow Microenvironment Identified as a Precursor to Myeloid MalignanciesThe Surface Geometry of Gold Prevents Oxidation by Rearranging Atoms
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
A novel immune organ inside the skull directs brain defense and may offer a new way to fight brain cancer and neurodegenerative diseaseThe oral exposure challenge in PROTACs: What drug developers need to solve earlyAttention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological LandscapeHarmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum Information
YOU MAY HAVE MISSED
Biotech & Genetic Research
A novel immune organ inside the skull directs brain defense and may offer a new way to fight brain cancer and neurodegenerative disease
Jia Lissa Sep 12, 2026
Laboratory Automation & Robotics
The oral exposure challenge in PROTACs: What drug developers need to solve early
Lana Keisha Sep 12, 2026
Neuroscience & Brain Research
Attention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological Landscape
Rifan Muazin Sep 12, 2026
Advanced Materials Science
Harmonic Shielding: Harvard Researchers Use Microscopic Sound Waves to Protect Fragile Quantum Information
Nila Kartika Wati Sep 12, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ